The application segmentation provides a clear market taxonomy that allocates the MEMS Microfluidics Devices market across five dominant verticals: biomedical, chemical analysis, environmental monitoring, industrial process control, and point‑of‑care diagnostics. In the biomedical arena, devices enable lab‑on‑a‑chip platforms for cell culture, drug screening, and tissue engineering, representing the largest share due to sustained funding and regulatory approvals. Chemical analysis applications leverage precise fluid handling for chromatography, spectroscopy, and reaction monitoring, driving demand for high‑accuracy flow sensors and mixers. Environmental monitoring utilizes ruggedized micro‑fluidic sensors to detect contaminants in water and air, a segment expanding with stricter regulatory standards. Industrial process control adopts micro‑valves and pumps for real‑time modulation of manufacturing lines, contributing steady revenue from automation initiatives. Point‑of‑care diagnostics, though smaller, is rapidly scaling as decentralized testing gains acceptance, relying heavily on integrated sensor‑pump combinations. This MEMS Microfluidics Devices segmentation underscores how each application area uniquely influences overall market dynamics.